FindTrial
Sign In

Effect of DIP score payment on drug cost and drug structure in elderly hypertensive inpatients: a multicenter, retrospective, observational study

Prescription analysis of hypertension drugs in medical institutions in nine regions of China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066973
Enrollment
Unknown
Registered
2022-12-22
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Drug Therapy Group:N/A

Sponsors

The First Affiliated Hospital, College of Medicine of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 120 Years

Inclusion criteria

Inclusion criteria: (1) Age = 60 years old; (2) Inpatients whose diagnosis includes hypertension; (3) The patients were discharged from the hospital from January 1, 2016 to December 31, 2020, and the departments of cardiology, neurosurgery, Cardiothoracic surgery.

Exclusion criteria

Exclusion criteria: Patients with incomplete data were excluded.

Design outcomes

Primary

MeasureTime frame
Monthly average daily drug expenses of inpatients with hypertension;—

Secondary

MeasureTime frame
The proportion of drug expenditure of each category per 100 RMB;—

Countries

China

Contacts

Public ContactDongsheng Hong

The First Affiliated Hospital, College of Medicine of Zhejiang University

hdswell@zju.edu.cn+86 13857180186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026